ClinicalTrials HQ

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Recruiting · NCT06652438 · Registry updated 2026-09-02
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AMLHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 32026-09-02NCT06652438

4 results · Page 1 of 1

200 results · Page 1 of 8

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AmsterdamumcAmsterdamNetherlands2
AT-Feldkirch-IKHFFeldkirchAustria2
AT-Linz-KEPLERLinzAustria2
AT-Salzburg-SALKSalzburgAustria3
AT-Vienna-HANUSCHViennaAustria4
AU-Adelaide-RAHAdelaideAustralia4
AU-Birtinya-SUNSHINECOASTUH General InformationBirtinyaAustralia1
AU-Brisbane-RBWHBrisbaneAustralia3
AU-Douglas-TOWNSVILLEDouglasAustralia3
AU-Melbourne-ALFREDMelbourneAustralia4
AU-Melbourne-MONASHMelbourneAustralia5
AU-Perth-FSHPerthAustralia3
AU-Perth-SCGHPerthAustralia3
AU-Sydney-RNSHSydneyAustralia4
AU-Sydney-SVSHSydneyAustralia1
BE-Antwerpen-ZASAntwerpBelgium3
BE-Brugge-AZBRUGGEBrugesBelgium6
BE-Brussel-BORDETBrusselsBelgium5
BE-Brussel-UZBRUSSELBrusselsBelgium3
BE-Bruxelles-STLUCBrusselsBelgium7
BE-Gent-UZGENTGhentBelgium7
BE-Hasselt-VIRGAJESSEHasseltBelgium3
BE-Leuven-UZLEUVENLeuvenBelgium10
BE-Liege-CHULIEGELiègeBelgium5
BE-Yvoir-MONTGODINNEYvoirBelgium5